Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

A092107

Trial Overview

Official Title

A Randomized Phase 2 Trial with a Safety Lead-In to Evaluate Palbociclib Versus Palbociclib and Cemiplimab for the Treatment of Advanced Dedifferentiated Liposarcoma

 

Study Purpose

Is the combination of palbociclib plus cemiplimab better than palbociclib alone in the treatment of advanced dedifferentiated liposarcoma that cannot be removed by surgery

Diagnosis

dedifferentiated liposarcoma that cannot be removed by surgery

Eligibility

Adults with advanced dedifferentiated liposarcoma that cannot be removed by surgery

Prior treatment allowed but some drugs may be excluded

Intervention

Palbociclib Versus Palbociclib and Cemiplimab

For more information, visit Clinicaltrials.gov

Key Participation Requirements
Trial Location(s)
Methodist Estabrook Cancer Center Methodist Jennie Edmundson Hospital
Gender
Male or Female
Age
19 and older
Enrollment Status
Recruiting
Phase
Phase II